Solid Biosciences Llc Stock Analysis
| SLDB Stock | USD 4.24 0.06 1.40% |
Solid Biosciences LLC is undervalued with Real Value of 6.87 and Target Price of 15.17. The main objective of Solid Biosciences stock analysis is to determine its intrinsic value, which is an estimate of what Solid Biosciences LLC is worth, separate from its market price. There are two main types of Solid Biosciences' stock analysis: fundamental analysis and technical analysis.
The Solid Biosciences stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Solid Biosciences' ongoing operational relationships across important fundamental and technical indicators.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Solid Biosciences LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. Solid Stock Analysis Notes
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.52. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Solid Biosciences LLC recorded a loss per share of 2.48. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 28th of October 2022. Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. Solid Biosciences Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts. Solid Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 104 people. To find out more about Solid Biosciences LLC contact Alexander Cumbo at 617 337 4680 or learn more at https://www.solidbio.com.Solid Biosciences LLC Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Solid Biosciences' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Solid Biosciences LLC or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Solid Biosciences generated a negative expected return over the last 90 days | |
| Solid Biosciences has high historical volatility and very poor performance | |
| Solid Biosciences has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (124.7 M) with loss before overhead, payroll, taxes, and interest of (96.43 M). | |
| Solid Biosciences LLC currently holds about 162.88 M in cash with (100.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.44. | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Disposition of 3278 shares by Ilan Ganot of Solid Biosciences at 4.12 subject to Rule 16b-3 |
Solid Biosciences LLC Upcoming and Recent Events
Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Solid Biosciences previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 28th of March 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Solid Largest EPS Surprises
Earnings surprises can significantly impact Solid Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-06 | 2024-09-30 | -0.67 | -0.79 | -0.12 | 17 | ||
2023-11-08 | 2023-09-30 | -1.19 | -1.05 | 0.14 | 11 | ||
2025-03-11 | 2024-12-31 | -0.7822 | -1.0 | -0.2178 | 27 |
Solid Biosciences Environmental, Social, and Governance (ESG) Scores
Solid Biosciences' ESG score is a quantitative measure that evaluates Solid Biosciences' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Solid Biosciences' operations that may have significant financial implications and affect Solid Biosciences' stock price as well as guide investors towards more socially responsible investments.
Solid Stock Institutional Investors
| Shares | Nantahala Capital Management, Llc | 2025-06-30 | 1.7 M | Alyeska Investment Group, L.p. | 2025-06-30 | 1.6 M | Mpm Oncology Impact Management Lp | 2025-06-30 | 1.6 M | Franklin Resources Inc | 2025-06-30 | 1.6 M | Geode Capital Management, Llc | 2025-06-30 | 1.5 M | Vestal Point Capital Lp | 2025-06-30 | 1.5 M | Point72 Asset Management, L.p. | 2025-06-30 | 1.3 M | Millennium Management Llc | 2025-06-30 | 1.1 M | Finepoint Capital Lp | 2025-06-30 | 961.3 K | Perceptive Advisors Llc | 2025-06-30 | 11.9 M | Bain Capital Life Sciences Investors, Llc | 2025-06-30 | 7.9 M |
Solid Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 335.01 M.Solid Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.66) | (0.69) | |
| Return On Capital Employed | (0.82) | (0.86) | |
| Return On Assets | (0.66) | (0.69) | |
| Return On Equity | (0.91) | (0.86) |
Management Efficiency
Solid Biosciences LLC has return on total asset (ROA) of (0.4367) % which means that it has lost $0.4367 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8683) %, meaning that it created substantial loss on money invested by shareholders. Solid Biosciences' management efficiency ratios could be used to measure how well Solid Biosciences manages its routine affairs as well as how well it operates its assets and liabilities. As of November 17, 2025, Return On Tangible Assets is expected to decline to -0.69. In addition to that, Return On Capital Employed is expected to decline to -0.86. At present, Solid Biosciences' Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.13, whereas Total Assets are forecasted to decline to about 157.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.36 | 3.19 | |
| Tangible Book Value Per Share | 3.36 | 3.19 | |
| Enterprise Value Over EBITDA | (0.88) | (0.84) | |
| Price Book Value Ratio | 1.19 | 1.25 | |
| Enterprise Value Multiple | (0.88) | (0.84) | |
| Price Fair Value | 1.19 | 1.25 |
Management at Solid Biosciences LLC focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Technical Drivers
As of the 17th of November 2025, Solid Biosciences has the Risk Adjusted Performance of (0.04), coefficient of variation of (1,212), and Variance of 27.46. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Solid Biosciences LLC, as well as the relationship between them.Solid Biosciences LLC Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Triple Exponential Moving Average (T3) indicator is developed by Tim Tillson as Solid Biosciences LLC price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Solid Biosciences LLC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Solid Biosciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Solid Biosciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Solid Biosciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Solid Biosciences Outstanding Bonds
Solid Biosciences issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Solid Biosciences LLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Solid bonds can be classified according to their maturity, which is the date when Solid Biosciences LLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Solid Biosciences Predictive Daily Indicators
Solid Biosciences intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Solid Biosciences stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Solid Biosciences Forecast Models
Solid Biosciences' time-series forecasting models are one of many Solid Biosciences' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Solid Biosciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Solid Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Solid Biosciences prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Solid shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Solid Biosciences. By using and applying Solid Stock analysis, traders can create a robust methodology for identifying Solid entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (12.22) | (12.83) | |
| Operating Profit Margin | (15.12) | (15.88) | |
| Net Loss | (12.22) | (12.83) | |
| Gross Profit Margin | 0.70 | 0.81 |
Current Solid Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Solid analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Solid analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 15.17 | Strong Buy | 12 | Odds |
Most Solid analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Solid stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Solid Biosciences LLC, talking to its executives and customers, or listening to Solid conference calls.
Solid Stock Analysis Indicators
Solid Biosciences LLC stock analysis indicators help investors evaluate how Solid Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Solid Biosciences shares will generate the highest return on investment. By understating and applying Solid Biosciences stock analysis, traders can identify Solid Biosciences position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 75.8 M | |
| Common Stock Shares Outstanding | 40.8 M | |
| Total Stockholder Equity | 137.2 M | |
| Total Cashflows From Investing Activities | -16.1 M | |
| Property Plant And Equipment Net | 29 M | |
| Cash And Short Term Investments | 148.9 M | |
| Cash | 80.2 M | |
| Accounts Payable | 4.2 M | |
| Net Debt | -56.1 M | |
| 50 Day M A | 5.449 | |
| Total Current Liabilities | 30.3 M | |
| Other Operating Expenses | 129.7 M | |
| Non Current Assets Total | 31.4 M | |
| Non Currrent Assets Other | 2.3 M | |
| Stock Based Compensation | 10.5 M |
Complementary Tools for Solid Stock analysis
When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |